SYLVAN
DEAD

Serial Number

90754272

Owner

Bausch Health Ireland Limited

Attorney

Jeremy Blackowicz

Filing Date

Jun 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

SYLVAN Trademark

Serial Number: 90754272

SYLVAN is a trademark filed by Bausch Health Ireland Limited on June 4, 2021. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Bausch Health Ireland Limited

3013 Lake Drive Citywest Business Campus

Entity Type: 99

Trademark Details

Filing Date

June 4, 2021

Registration Date

Not Registered

Goods & Services

Non-medicated dermatologic substances and preparations, namely, moisturizers, creams, powders, gels, solutions, shampoos, sprays, swabs, washes, ointments, Non-medicated oral health substances preparations in the form of powders, creams, rinses for the treatment of periodontitis, mouth dryness, cold sores, mouth ulcers

Radio frequency medical devices for contracting skin, body sculpting, and soft tissue reconstruction in a non-invasive manner; Medical devices for aesthetic and therapeutic applications for the skin and its subcutaneous structures, namely, a device for delivering energy to the skin and its underlying tissues; Lasers and radio frequency devices for medical and aesthetic treatment; Medical devices, namely, medical instruments designed for the non-invasive removal of human body fat using an external energy source

Pharmaceutical preparations and substances for diagnosis and treatment of oral disease, namely, periodontitis, oral mucositis and bone and soft tissue regeneration, Dental rinse for oral health, Medicated pharmaceutical preparations and substances for the treatment and prevention of gastrointestinal diseases and disorders in humans including constipation, hepatic encephalopathy, irritable bowel syndrome, opioid-induced constipation and ulcerative colitis, Medicated beverages, powders, and gels for colonoscopies and endoscopic procedures, Pharmaceutical preparations and substances to prevent and treat diabetes mellitus, epilepsy, migraines, anxiety and depression, chronic pain, headaches, psychiatric disorders, and rare diseases such as Wilson and Huntington's disease, diabetes mellitus, cardiovascular/angina, hyperammonemia, hormone deficiencies (endocrinology), cancer, otolaryngology, and urinary tract, lungs, heart infections and diseases, central nervous system disorders, neuromuscular conditions, vaginal disorders, Pharmaceutical preparations for treating allergic rhinitis and asthma, Pharmaceutical preparations and substances for the treatment of skin and nail conditions, namely, acne, psoriasis, onychomycosis, tinea pedis, actinic keratosis, rosacea and other dermatoses, fungal infections, topical antibiotics to treat atopic dermatitis, actinic keratosis, acne, rosacea, psoriasis, athlete's foot, nail fungus and other skin ailments, conditions and dermatoses, Vitamins and mineral supplements

Filing History

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Feb 11, 2026 ASCK
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 22, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 22, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 22, 2022 REAP
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Jul 22, 2022 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Jul 22, 2022 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 22, 2022 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 7, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jan 7, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jan 7, 2022 CNRT
ASSIGNED TO EXAMINER
Dec 20, 2021 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 16, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 16, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 16, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 16, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 16, 2021 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 26, 2021 NWOS
NEW APPLICATION ENTERED
Jun 8, 2021 NWAP